Figure 2.

Kaplan–Meier survival analysis of keratolimbal allograft (2.00) (66.7 ± 15.7% and 53.3 ± 17.3% for 12 and 18 months, respectively) and living-related conjunctival limbal allograft (lr-CLAL) (1.00) (65 ± 10.7%, 54.2 ± 11.2%, and 36.6 ± 11.4% for the first, second, and third postoperative years, respectively)